Joshua H. Bilenker, President & CEO at Loxo Oncology, Inc. (LOXO), sold 10,000 shares at $166.52 ($1.7M) on 2018-09-13, disclosed to the SEC on 2018-09-14.
Open-market sale of $1.7M LOXO by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $165.43 | 5,636 | $932K | 56.2% |
| 2 | $166.52 | 3,402 | $567K | 34.1% |
| 3 | $167.32 | 962 | $161K | 9.7% |
| Total | $165.98 avg | 10,000 | $1.7M | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $2.7M | — | Filing → |
| LOXO | SELL | 2018-12-12 | $1.0M | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.2M | — | Filing → |